FOLH1 and neoplasm: There are two potential explanations for the higher detection rate in patients with ADT: a higher PSMA-expression induced by ADT in tumor cells and thus, a higher visibility of tumor lesions, or higher tumor burden related to an advanced disease stage of patients with ADT.